AbbVie United States And Puerto Rico — Total long-lived assets increased by 2.2% to $3.40B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.2%, from $3.33B to $3.40B.
An increase suggests significant capital investment or acquisition activity within the region, while a decrease may indicate asset divestitures, depreciation, or a shift in the geographic focus of operations.
This metric represents the total carrying value of non-current, tangible, and intangible assets located within the Unite...
Peers in the pharmaceutical industry typically report similar geographic breakdowns of long-lived assets to demonstrate their reliance on domestic versus international manufacturing and R&D hubs.
abbv_segment_united_states_total_long_lived_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $3.37B | $3.24B | $3.14B | $3.33B | $3.40B |
| QoQ Change | — | -3.7% | -3.2% | +6.1% | +2.2% |
| YoY Change | — | -3.7% | -3.2% | +6.1% | +2.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.